Kisspeptin-10 vs Triptorelin — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Kisspeptin-10 is the minimal biologically active fragment of kisspeptin - the peptide product of the KISS1 gene that acts as the master regulator of reproductive axis activation. It acts exclusively on the kisspeptin receptor (KISS1R / GPR54), which is expressed on hypothalamic G...
Calculate Kisspeptin-10 dose →Triptorelin is a GnRH agonist with a D-tryptophan substitution at position 6, which confers resistance to enzymatic degradation and extends activity compared to native GnRH. FDA approved as Trelstar for prostate cancer, endometriosis, and central precocious puberty via long-actin...
Calculate Triptorelin dose →| Parameter | Kisspeptin-10 | Triptorelin |
|---|---|---|
| Category | Reproductive & Hormonal | Reproductive & Hormonal |
| Research | Extensively Studied | FDA Approved (oncology) |
| Half-Life | ~28–30 min | ~3–6 hours (aqueous); months (microsphere depot) |
| Typical Dose | 1–10 µg/kg (clinical); 0.5–2 mg (research) | 100 µg (PCT single dose) / 3.75–11.25 mg (oncology depot) |
| Frequency | Pulsatile (every 90 min) or bolus as needed | Single dose (PCT) or monthly/quarterly (oncology) |
| Route | Subcutaneous / Intravenous (clinical) | Subcutaneous (aqueous) / IM (depot) |
| FDA Status | Not Approved | Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.